Link to article Melbourne, Australia – 11 February 2022: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce it has completed the first production run of the next generation Hailie® sensors with physiological parameters for monitoring Asthma and Chronic Obstructive Pulmonary Disease (COPD) medication use. […]
Biomedical projects at the cutting edge of innovation will receive a $25m cash injection, in a boost for next-gen medicine including stem cell research, new treatments for autism and a technology that allows medicine to be taken through the skin. The $25m investment through the federal Biomedical Translation Fund will potentially benefit thousands of Australians […]
An Australian backed and enabled “smart” orthopaedic knee implant set to revolutionise knee replacements has been given marketing authorisation by the US Food and Drug Administration. The canturioTMte device has been backed by Melbourne-based healthcare investment firm, BioScience Managers (BSM) to assist with the aggregation of patient data for software developed by Melbourne-based healthcare informatics […]
Link to full article Cambridge, UK, 11 October 2021: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, continues to build a strong patent portfolio protecting its proprietary Arestat™ technology. Arecor is pleased to announce that its European patent EP2457590 on polysaccharide vaccines has been successfully upheld following opposition […]
The West Australian Tue, 19 October 2021 3:13PM WA-based Hall and Prior will be the first Australian aged care provider to roll-out a new “world-first” platform designed to reduce human error in the sector. The software developed by Australian company Humanetix automates administration work to free-up time for carers by up to 96 minutes per […]
Link to full article Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that it has been awarded a contract for supply of the Hailie® solution to an upcoming US-based clinical study by AstraZeneca. Adherium will be providing a bespoke version of its Hailie® sensor and software […]
Link to full article August 30, 2021— Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Canary Medical, a medical data company, today announced U.S. Food and Drug Administration (FDA) DeNovo classification grant and authorization to market the tibial extension for PersonaIQ®, the world’s first and only smart knee cleared […]
Link to Full Article MIP Diagnostics, a UK manufacturer of molecularly imprinted polymers (MIPs) has achieved ISO 9001:2015 accreditation. MIP Diagnostics specialise in the development and manufacture of nanoscale molecularly imprinted polymers (nanoMIPs), which act as synthetic antibodies in diagnostic assays, sensors and other industry applications. After a strong start to 2021, MIP Diagnostics has […]
Link to Full Article MIP Diagnostics Ltd. has today announced the launch of its COVID-19 nanoMIP for diagnostic sensors, a synthetic alternative to antibodies that offers ultra-high sensitivity for the next wave of COVID-19 antigen detecting devices. nanoMIPs are nanoscale Molecularly Imprinted Polymers, commonly known as synthetic antibodies. They are manufactured around a template molecule […]
Link to Full Article We are pleased to announce the appointment of Mike Dalrymple to the role of Head of Global Business Development at MIP Diagnostics on a consultancy basis. With over 30 years’ experience in diagnostics and therapeutics, Mike brings a wealth of knowledge and expertise to the business. Mike has a long track […]